Congo launches trial of Bundibugyo Ebola vaccine amid ongoing outbreak

A trial of Merck's Ervebo and an experimental Moderna vaccine against the Bundibugyo Ebola species has begun in Bunia, DRC, where the outbreak is concentrated. The trial tests cross-protection and a new mRNA candidate, but efficacy data will take months. This is the first targeted response to a strain that has historically lacked a licensed vaccine.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works